These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37120341)

  • 1. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
    Matoba D; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Doki Y; Eguchi H
    Transplant Proc; 2023 May; 55(4):893-897. PubMed ID: 37120341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.
    Jiang L; Yan L; Tan Y; Li B; Wen T; Yang J; Zhao J
    Surg Today; 2013 Sep; 43(9):1039-48. PubMed ID: 23467980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of living donor liver transplantation in graft survival for extremely high model for end-stage liver disease score ≥35.
    Yun SO; Kim J; Rhu J; Choi GS; Joh JW
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1293-1303. PubMed ID: 37799067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS; Chen TH; Jeng LB; Yang HR; Li PC; Lee CC; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ; Tsai PP
    Transplant Proc; 2012 Mar; 44(2):316-9. PubMed ID: 22410005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation.
    Ikegami T; Shirabe K; Yoshiya S; Yoshizumi T; Yamashita Y; Harimoto N; Toshima T; Uchiyama H; Soejima Y; Maehara Y
    Surg Today; 2014 Feb; 44(2):233-40. PubMed ID: 23435837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T; Moonka D; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S
    Liver Transpl; 2021 Jul; 27(7):971-983. PubMed ID: 33492764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis.
    Kong L; Lv T; Jiang L; Yang J; Yang J
    BMC Surg; 2020 Nov; 20(1):290. PubMed ID: 33218334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of <20.
    Yanagaki M; Onda S; Furukawa K; Taniai T; Haruki K; Akaoka M; Shirai Y; Matsumoto M; Gocho T; Uwagawa T; Ikegami T
    Transplant Proc; 2023 May; 55(4):898-900. PubMed ID: 37095011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Rosenthal BE; Abt PL; Schaubel DE; Reddy KR; Bittermann T
    Transplantation; 2024 Mar; 108(3):713-723. PubMed ID: 37635282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
    Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
    World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.